| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 230.858 | 195.707 | 183.650 | 204.237 | 208.769 | 264.333 | 241.354 | 270.930 | 321.877 | 371.786 |
| Total Income - EUR | 230.860 | 197.649 | 183.650 | 204.882 | 215.944 | 267.456 | 244.281 | 271.180 | 322.451 | 384.138 |
| Total Expenses - EUR | 219.562 | 199.390 | 186.292 | 202.511 | 213.459 | 264.533 | 241.456 | 260.959 | 325.007 | 393.504 |
| Gross Profit/Loss - EUR | 11.298 | -1.741 | -2.641 | 2.371 | 2.486 | 2.923 | 2.825 | 10.221 | -2.556 | -9.366 |
| Net Profit/Loss - EUR | 9.611 | -1.955 | -2.993 | 322 | 232 | 249 | 382 | 7.510 | -5.780 | -9.999 |
| Employees | 8 | 8 | 6 | 0 | 6 | 6 | 5 | 4 | 4 | 0 |
Check the financial reports for the company - Propharma Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.459 | 3.459 | 4.869 | 9.772 | 8.164 | 8.120 | 7.410 | 10.586 | 10.588 | 10.090 |
| Current Assets | 90.245 | 60.826 | 80.760 | 155.708 | 215.789 | 193.964 | 227.976 | 236.660 | 243.111 | 147.615 |
| Inventories | 18.074 | 13.324 | 12.010 | 29.967 | 41.872 | 48.235 | 65.348 | 80.576 | 53.499 | 31.581 |
| Receivables | 33.365 | 10.070 | 65.893 | 124.492 | 169.950 | 142.044 | 155.032 | 148.795 | 176.072 | 109.553 |
| Cash | 38.806 | 37.432 | 2.857 | 1.250 | 3.967 | 3.686 | 7.595 | 7.289 | 13.541 | 6.480 |
| Shareholders Funds | 21.976 | 4.615 | 1.474 | 4.720 | 4.842 | 4.999 | -1.834 | 5.670 | -870 | -10.864 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 72.728 | 59.670 | 84.154 | 160.760 | 219.111 | 197.085 | 237.219 | 241.577 | 254.569 | 168.569 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4673
|
|||||||||
Comments - Propharma Med S.r.l.